Author(s): Bhogal N, Grindon C, Combes R, Balls M
Abstract Share this page
Abstract Biotechnology is evolving at a tremendous rate. Although drug discovery is now heavily focused on high throughput and miniaturized screening, the application of these advances to the toxicological assessment of chemicals and chemical products has been slow. Nevertheless, the impending surge in demands for the regulatory toxicity testing of chemicals provides the impetus for the incorporation of novel methodologies into hazard identification and risk assessment. Here, we review the current and likely future value of these new technologies in relation to toxicological evaluation and the protection of human health.
This article was published in Trends Biotechnol
and referenced in Journal of Drug Metabolism & Toxicology